Cardiovascular Benefits of Wegovy Extend Beyond Weight Loss, Study Shows

October 22, 2025

•

1 min read

•

The New York Times

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in people who took Wegovy.

A new analysis of a major clinical trial affirmed that Wegovy, the popular obesity drug, lowers the risk of major heart issues like heart attacks and strokes in some adults, but showed that weight loss could not fully explain the cardiovascular benef... [4009 chars]

Read Original Article

Source: The New York Times

Visit Source

Share this article

Twitter Facebook

Back to health news